{"title":"Micromeria graeca L., essential Oils: In vitro and In silico evaluation","authors":"Mustapha Laghmari , Jihane Touhtouh , Tarik Aanniz , Gökhan Zengin , Abdelhakim Bouyahya , Riaz Ullah , Amal Alotaibi , Mohamed Akhazzane , Taoufiq Benali , Khalil Hammani","doi":"10.1016/j.bse.2025.105071","DOIUrl":null,"url":null,"abstract":"<div><div>The discovery of new natural molecules with therapeutic and/or cosmetic properties is a major concern of the pharmaceutical industry. In this sense, volatile compounds from plants have recently attracted significant interest as candidate natural substances. The aims of this research were to identify the volatile compounds of <em>Micromeria graeca</em> essential oil (MGEO) and to study its antimicrobial, antioxidant, and anti-enzymatic effects using <em>in vitro</em> and computational approaches, including molecular docking and molecular dynamics interaction studies. Gas chromatography coupled with mass spectrometry (GC-MS-MS) analysis revealed that MGEO contain 17 chemical compounds which were dominated by citral (29.3 %), neral (16.3 %), and caryophyllene oxide (10.4 %). The disc diffusion method and the broth microdilution techniques demonstrated that MGEO significantly inhibits the growth of <em>Bacillus subtilis</em>, <em>Proteus mirabilis</em>, <em>Staphyloccocus aureus</em>, and <em>Candida albicans</em> which the inhibition zone diameters ranged between 51 and 71 mm and MIC values ranged from 1.56 to superior to 50 mg/mL. The antioxidant effects indicate that MGEO exerts an important activity in 2,2′-diphenyl-1-picrylhydrazyl (DPPH), 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), ferric reducing antioxidant power (FRAP), cupric ion reducing activity (CUPRAC), ferrous chelating, and phosphomolybdenum models. Indeed, MGEO exerted significant antioxidant activity in several assays, demonstrating antioxidant powers with inhibitory values of 84.02 ± 3.25 mg TE/g of EO (Cuprac), 47.67 ± 0.22 mg TE/g of EO (ABTS), 45.45 ± 0.26 mg TE/g of EO (FRAP), 28.90 ± 1.19 mmol TE/g (Phosphomolybdenum), 22.41 ± 3.00 mg EDTAE/g of EO (Chelating), and 9.04 ± 0.67 mg TE/g of EO (DPPH). Remarkably, MGEO shows good potential to inhibit tyrosinase (41.05 mg KAE/g), butyrylcholinesterase and acetylcholinesterase (2.06 and 1.68 mg GALAE/g, respectively), and α-amylase (0.87 mmol ACAE/g) enzymes. Additionally, the molecular docking study demonstrated that each chemical interacted differently with the active regions of the five different enzymes. Collectively, our findings provides valuable information qualifying the studied plant as an interesting source of bioactive compounds.</div></div>","PeriodicalId":8799,"journal":{"name":"Biochemical Systematics and Ecology","volume":"123 ","pages":"Article 105071"},"PeriodicalIF":1.4000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Systematics and Ecology","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305197825001206","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The discovery of new natural molecules with therapeutic and/or cosmetic properties is a major concern of the pharmaceutical industry. In this sense, volatile compounds from plants have recently attracted significant interest as candidate natural substances. The aims of this research were to identify the volatile compounds of Micromeria graeca essential oil (MGEO) and to study its antimicrobial, antioxidant, and anti-enzymatic effects using in vitro and computational approaches, including molecular docking and molecular dynamics interaction studies. Gas chromatography coupled with mass spectrometry (GC-MS-MS) analysis revealed that MGEO contain 17 chemical compounds which were dominated by citral (29.3 %), neral (16.3 %), and caryophyllene oxide (10.4 %). The disc diffusion method and the broth microdilution techniques demonstrated that MGEO significantly inhibits the growth of Bacillus subtilis, Proteus mirabilis, Staphyloccocus aureus, and Candida albicans which the inhibition zone diameters ranged between 51 and 71 mm and MIC values ranged from 1.56 to superior to 50 mg/mL. The antioxidant effects indicate that MGEO exerts an important activity in 2,2′-diphenyl-1-picrylhydrazyl (DPPH), 2,2- azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), ferric reducing antioxidant power (FRAP), cupric ion reducing activity (CUPRAC), ferrous chelating, and phosphomolybdenum models. Indeed, MGEO exerted significant antioxidant activity in several assays, demonstrating antioxidant powers with inhibitory values of 84.02 ± 3.25 mg TE/g of EO (Cuprac), 47.67 ± 0.22 mg TE/g of EO (ABTS), 45.45 ± 0.26 mg TE/g of EO (FRAP), 28.90 ± 1.19 mmol TE/g (Phosphomolybdenum), 22.41 ± 3.00 mg EDTAE/g of EO (Chelating), and 9.04 ± 0.67 mg TE/g of EO (DPPH). Remarkably, MGEO shows good potential to inhibit tyrosinase (41.05 mg KAE/g), butyrylcholinesterase and acetylcholinesterase (2.06 and 1.68 mg GALAE/g, respectively), and α-amylase (0.87 mmol ACAE/g) enzymes. Additionally, the molecular docking study demonstrated that each chemical interacted differently with the active regions of the five different enzymes. Collectively, our findings provides valuable information qualifying the studied plant as an interesting source of bioactive compounds.
期刊介绍:
Biochemical Systematics and Ecology is devoted to the publication of original papers and reviews, both submitted and invited, in two subject areas: I) the application of biochemistry to problems relating to systematic biology of organisms (biochemical systematics); II) the role of biochemistry in interactions between organisms or between an organism and its environment (biochemical ecology).
In the Biochemical Systematics subject area, comparative studies of the distribution of (secondary) metabolites within a wider taxon (e.g. genus or family) are welcome. Comparative studies, encompassing multiple accessions of each of the taxa within their distribution are particularly encouraged. Welcome are also studies combining classical chemosystematic studies (such as comparative HPLC-MS or GC-MS investigations) with (macro-) molecular phylogenetic studies. Studies that involve the comparative use of compounds to help differentiate among species such as adulterants or substitutes that illustrate the applied use of chemosystematics are welcome. In contrast, studies solely employing macromolecular phylogenetic techniques (gene sequences, RAPD studies etc.) will be considered out of scope. Discouraged are manuscripts that report known or new compounds from a single source taxon without addressing a systematic hypothesis. Also considered out of scope are studies using outdated and hard to reproduce macromolecular techniques such as RAPDs in combination with standard chemosystematic techniques such as GC-FID and GC-MS.